Results 61 to 70 of about 528,622 (127)
Abstract A 6‐year‐old spayed female Golden Retriever mix was diagnosed with immune‐mediated haemolytic anaemia. Initial treatments included immunosuppression and blood transfusions. With acute mentation decline and rapid increase in serum bilirubin, therapeutic plasma exchange (TPE) was initiated.
Natasha S. Yeh +2 more
wiley +1 more source
Excessive apixaban concentrations in a bleeding patient leading to impaired coagulation and treatment with pharmacological reversal and extracorporal removal. ABSTRACT In trauma, even therapeutic apixaban levels can significantly exacerbate bleeding.
Richard Felix Kraus +6 more
wiley +1 more source
Ticagrelor removal by CytoSorb® in patients requiring emergent or urgent cardiac surgery: a UK-based cost-utility analysis [PDF]
Background: Acute coronary syndrome patients receiving dual antiplatelet therapy who need emergent or urgent cardiac surgery are at high risk of major bleeding, which can impair postoperative outcomes.
core +1 more source
CytoSorb use in critically ill patients with hyperbilirubinemia
CytoSorb, a relatively new blood purification technique is gaining popularity with different indications in critically ill patients. Our aim is to summarize currently available data on CytoSorb use in critically ill patients with acquired hepatic injury ...
Klementina Ocskay
core +1 more source
The therapy with PAP using BR‐350 resulted in a significant decrease of bilirubin concentrations. The median relative reduction of bilirubin was comparable between PAP and OPAL (47% vs. 40%, p = 0.29). The crossover comparison between the single session of PAP using BR‐350 and OPAL revealed similar relative reduction rates of bilirubin.
Justa Friebus‐Kardash +8 more
wiley +1 more source
Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support
Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov +11 more
wiley +1 more source
Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillosis or mucormycosis. The objective of this study was to evaluate ISA levels in a real world setting in a mixed patient cohort including patients with non ...
Christoph Zurl +14 more
doaj +1 more source
Septic shock is associated with high mortality worldwide despite adequate treatment. Various blood purification techniques have been available on the market for several years, aiming to remove circulating inflammatory mediators and to attenuate life‐threatening cytokine storms.
Erich Moresco +4 more
wiley +1 more source
Feasibility and Safety of Cytosorb Application in Patients With Acute Liver Failure
ABSTRACT Background and Aims Acute liver failure (ALF) is a rare, life‐threatening condition with high mortality and limited therapeutic options beyond liver transplantation. Cytosorb adsorber can be easily applied to continuous renal replacement therapy (CRRT) and potentially support liver function by removing bilirubin and cytokines.
Patrick Haselwanter +10 more
wiley +1 more source
Circulating histones as clinical biomarkers in critically ill conditions
Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez +17 more
wiley +1 more source

